Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04026334 · ClinicalTrials.gov registry record · NA
Evaluation of V.A.C. VERAFLO CLEANSE CHOICE™ Dressing Using Normal Saline to Promote Increased Healthy Wound Bed Tissue
A NA study, sponsored by 3M.
- Terminated
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT04026334 is a NA study that was terminated before completion, run by 3M. The registered enrollment target is 8 participants.
The verdict
NCT04026334, a NA study, was terminated before completion, sponsored by 3M.
- TERMINATED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
The study goal is to evaluate the ability of the V.A.C. ULTA™ Negative Pressure Wound Therapy System and V.A.C. VERAFLO CLEANSE CHOICE ™ (VFCC) dressing system with saline as an irrigant in increasing viable tissue in full thickness wounds (such as chronic, acute, traumatic, sub-acute, and dehisced wounds and/or ulcers) with difficult to manage bioburden and slough.
Interventions
- DEVICE V.A.C. VERAFLO CLEANSE CHOICE™ dressing with Normal Saline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2019-07-25 |
| Est. Completion | 2020-08-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04026334
The ClinicalTrials.gov registry entry for NCT04026334 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is 3M, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which V.A.C. VERAFLO CLEANSE CHOICE™ dressing with Normal Saline is the first listed.
NCT04026334 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04026334 about?
NCT04026334 is a clinical study titled "Evaluation of V.A.C. VERAFLO CLEANSE CHOICE™ Dressing Using Normal Saline to Promote Increased Healthy Wound Bed Tissue". The study goal is to evaluate the ability of the V.A.C. ULTA™ Negative Pressure Wound Therapy System and V.A.C. VERAFLO CLEANSE CHOICE ™ (VFCC) dressing system with saline as an irrigant in increasing viable tissue in full thickness wounds (such as chronic, acute, traumatic, sub-acute, and dehisced ...
What is the current status of trial NCT04026334?
This trial is currently terminated. It is a NA study. The enrollment target is 8 participants. The study started on 2019-07-25. Estimated completion is 2020-08-28.
What interventions are being tested in trial NCT04026334?
The interventions under investigation include: V.A.C. VERAFLO CLEANSE CHOICE™ dressing with Normal Saline (DEVICE).
Who is sponsoring clinical trial NCT04026334?
This trial is sponsored by 3M, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.